Copyright © 2025 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{167204,
        author = {Shraddha Pawar and Dr. Sachin Kumar Jain},
        title = {A Study of Extracts of Rheum emodi in Experimental Non-Alcoholic Fatty Liver Disease},
        journal = {International Journal of Innovative Research in Technology},
        year = {2024},
        volume = {11},
        number = {3},
        pages = {576-583},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=167204},
        abstract = {Paracetamol (PCM) is a commonly used analgesic and antipyretic medication, however at large doses, it can cause hepatotoxicity/NAFLD. This study explores the therapeutic potential of Rheum e.modi extracts in treating experimental non-alcoholic fatty liver disease (NAFLD), a liver disorder linked to metabolic syndrome, based on its diverse phytochemical composition against paracetamol-induced damage. This study aims to evaluate the hepatoprotective effects of Rheum e.modi extracts on NAFLD in an experimental model, conduct histopathological examination of liver tissues, investigate the potential of Rheum e.modi extracts in modulating metabolic pathways related to lipid metabolism, insulin sensitivity, and glucose homeostasis, and establish a dose-response relationship to determine the optimal dosage for significant therapeutic effects while ensuring safety.},
        keywords = {NAFLD, Rheum e.modi, paracetamol, hepatotoxicity, hepatoprotective},
        month = {October},
        }